Molecular Target Synopsis
Overview
Domains and Structures
Drugs and Clinical Candidates
Druggability
Chemistry
Ligand Efficiency Plot
Pathways
Family Cladogram
Interaction Network
Gene Expression
Gene Copy Number Variation
RNAi
Mutations
Germline Genetics

RIMBP3C (A6NJZ7) - Druggability - Molecular Target Synopsis

Chain-based assessment (last updated 23/07/2019)
Structural Druggability Help: Help

Chain-based assessment (last updated 23/07/2019)


Chains assessed1
Chains with at least one site assessed as druggable using the strict criteria0
Chains with at least one site assessed as druggable using the relaxed criteria0


		
PDB Chain Protein Name Druggable Relaxed Druggable Strict Details
2EGE_A RIMS-binding protein 3C No No show/hide
Site num Site Status Pickpocket Polar Ratio Surfnet Gap Vertices Buried Surfnet Long Axis Druggable Relaxed Druggable Strict
1 empty 2.28 60.1 19.2 No No
2 empty 2.85 62 22.4 No No
3 empty 1.75 55.9 15.7 No No
4 empty 1.91 59.3 16.2 No No
5 empty 2.93 68 6.3 No No
6 empty 2.17 57.6 6 No No
7 empty 1.54 60.7 7.3 No No
8 empty 2.59 68.3 6.6 No No
9 empty 1.34 19.5 6.3 No No
10 empty 3.11 54.2 5.4 No No
Ligand-based Druggability Score: -0.45
Ligand-based Druggability Score Percentile: 74%
Ligand-based Druggability Help: Help




		
Number of proteins in the network : 13346


RIMBP3C is involved in 1 interactions in the network.


Druggability
Overall Druggability Percentile: 60.47
Druggability for Cancer Therapeutics: 41.46
Druggability for Other Therapeutics: 73.19
Cancer-Associated
Cancer-associated percentile : 16.58
Network Articulation Point
Is RIMBP3C critical for communication in the network?


Detailed Graph Legend:Help